Search clinical trials for: HIV seronegativity

Total 12889 results

National Institute of Allergy and Infectious Diseases...

Completed

Safety of an HIV DNA Vaccine Given to HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a Combination HIV Vaccine Regimen in HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to an HIV Preventive Vaccine (HIV-1 Gag DNA Alone or With IL-15 DNA) Given With or Without 2 Different Booster Vaccinations in HIV Uninfected Adults

HIV Infections

United States, Brazil
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety of and Immune Response to Two HIV Vaccines: SAAVI DNA-C2 Boosted With SAAVIMVA-C, in HIV-Negative Adults

HIV Infections

United States, South Africa
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to Two Different HIV Vaccines, Each Followed by a Adenoviral Vaccine Boost, in HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

An Investigational Combination Vaccine Given to People Who Are Not Infected With HIV

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to an HIV Vaccine (VRC-HIVDNA009-00-VP) Administered With Interleukin-2/Immunoglobulin (IL-2/Ig) DNA Adjuvant in Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to a New HIV Vaccine: HIV CTL MEP

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune System Response to an HIV Vaccine (EP HIV-1090) in HIV Uninfected Adults

HIV Infections

Botswana, United States
National Institute of Allergy and Infectious Diseases...

Completed

Immune Response to an HIV DNA Plasmid Vaccine Prime Followed by Adenovirus Boost in HIV-uninfected Individuals

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

HIV Infections | HIV Seronegativity

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to Two HIV Vaccine Formulations (rMVA-HIV and rFPV-HIV) Alone or in Combination in HIV Uninfected Adults

HIV Infections

United States, Brazil
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Effectiveness of PENNVAX-B Vaccine Alone, With Il-12, or IL-15 in Healthy Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to an HIV-1 Vaccine Boost (VRC-HIVADV014-00-VP) in HIV Uninfected Adults Who Participated in HVTN 052

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...
HIV Vaccine Trials Network

Completed

Safety and Immune Response to Preventive HIV Immunization With Adenovirus Serotype 5 or 35 Vector

HIV Infections

United States
University of California, Los Angeles

Active, not recruiting

Neighborhood Alcohol & HIV Prevention in South African Townships (Philani)

Nutrition Disorders | HIV | Fetal Alcohol Syndrome

South Africa
National Institute of Allergy and Infectious Diseases...

Completed

ALVAC-HIV vCP1452 Alone and Combined With MN rgp120

HIV Infections | HIV Seronegativity

Brazil, Peru, Haiti, Trinidad and Tobago
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults

HIV Infections

United States
National Institute of Allergy and Infectious Diseases...

Completed

Safety of and Immune Response to the Experimental Preventive HIV Vaccine, EP HIV-1090, in Healthy, HIV-1 Uninfected Adults

HIV Infections

United States
University of California, San Diego
University of Southern California; Lundquist Institute for Biomedical Innovation... and other collaborators

Completed

Randomized Controlled Trial of iTAB Plus Motivational Interviewing for PrEP Adherence in Transgender Individuals

HIV Seronegativity | Patient Adherence

United States
University of California, San Diego
Los Angeles LGBT Center

Completed

Linkage of Transgender Individuals to PrEP

HIV Seronegativity | Linkage

United States
Novartis

Completed

Evaluation of HIV-1, HCV and HBV Blood Screening Tests With Human Blood Donor Specimens

Screening for the Presence of HIV-1, RNA and HBV DNA in Blood Donations

Taiwan
Centers for Disease Control and Prevention
Ministry of Health, Thailand; Bangkok Metropolitan Administration Medical College...

Completed

Bangkok Tenofovir Study, an HIV Pre-exposure Prophylaxis Trial, Bangkok, Thailand

HIV Infections

Thailand
Elizabeth Glaser Pediatric AIDS Foundation
Harvard School of Public Health (HSPH); Centre for Infectious Disease Research... and other collaborators

Completed

Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol (MEPProject)

HIV Infections | Pregnant Women | HIV Positive

South Africa, Zambia
bioLytical Laboratories

Completed

Testing of INSTI™ HIV-1 Antibody Test Kit in Volunteer Subjects at Risk for HIV Infection

HIV Infections

United States
University of California, San Diego
University of California, Los Angeles; Gilead Sciences; University of Southern... and other collaborators

Completed

CCTG 595: Text Messaging Intervention to Improve Adherence to PrEP in High-risk MSM

HIV Seronegativity | Patient Adherence

United States
University of California, San Diego

Completed

Pre-exposure Prophylaxis Accessibility Research and Evaluation 2 (PrEPARE2)

HIV Seronegativity | PrEP Uptake

United States
Steffanie Strathdee
National Institute on Drug Abuse (NIDA); San Diego State University; University... and other collaborators

Completed

Behavioral Intervention to Reduce Sexual and Injection Risks Among Female Sex Workers Who Also Inject Drugs in Mexico (FSW-IDU)

HIV Infections | HIV

Mexico
Yale University
Boehringer Ingelheim

Completed

Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir (BUTI)

HIV Infections

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Group Prenatal Care for Reducing the Risk of STDs in Pregnant Young Women

HIV Infections | Sexually Transmitted Diseases

United States
Yale University
Robert Wood Johnson Foundation

Completed

Reducing Sex-Related HIV Risk Behaviors in Patients Receiving Treatment for Opioid Dependence (Project RED)

HIV Infections | Opiate Dependence

United States
Yale University
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

HIV Infections | Sexually Transmitted Diseases | Pregnancy

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Brief Introductory Therapy for Opioid Dependence

HIV Infections | Opiate Dependence

United States
Yale University
National Institute on Drug Abuse (NIDA)

Withdrawn

HIV Risk Reduction and Drug Abuse Treatment in Iran

HIV Infections | Opiate Dependence

United States, Iran, Islamic Republic of
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China

HIV Infections | Opiate Dependence

China, United States
ViiV Healthcare
GlaxoSmithKline

Completed

A Study to Assess Relative Bioavailability and Food Effect of New Formulations of GSK2248761

HIV Infections | Infection, Human Immunodeficiency Virus

United States
Centers for Disease Control and Prevention
Gilead Sciences; Botswana Ministry of Health

Completed

Botswana TDF/FTC Oral HIV Prophylaxis Trial (TDF2)

HIV Infections

United States, Botswana
National Institute of Allergy and Infectious Diseases...

Completed

Screening Protocol for HIV Vaccine Studies

HIV Infections | HIV Seronegativity

United States
University of Illinois at Chicago
National Institute of Mental Health (NIMH)

Completed

Internet-based HIV/STI Prevention for Young MSM Receiving HIV Testing (KIU)

HIV Infections | HIV

United States
Imperial College London
Biomedical Research and Training Institute

Completed

Scientific Evaluation of Peer Education and STD Treatment to Reduce the Spread of HIV in Zimbabwe

HIV Infections

Zimbabwe
University of Southern California
National Institute of Mental Health (NIMH)

Completed

The SOLVE-IT National Randomized Trial (SOLVE-IT)

HIV Infections

United States
Medical College of Wisconsin
National Institute of Mental Health (NIMH)

Completed

Effectiveness of Communication Technology in Disseminating HIV Prevention Training to Non-governmental Organizations

HIV Infections

United States
HIV Vaccine Trials Network
South Africa AIDS Vaccine Initiative

Completed

Safety of and Immune Response to a DNA HIV Vaccine Boosted With a Modified Vaccinia HIV Vaccine and Protein HIV Vaccine in Healthy Adults

HIV Seronegativity | HIV Preventive Vaccine

South Africa
U.S. Army Medical Research and Development Command
Walter Reed Army Institute of Research (WRAIR); Mahidol University; The Emmes... and other collaborators

Completed

HIV Vaccine Trial in Thai Adults

HIV Infection

Thailand
University of Washington
Bill and Melinda Gates Foundation

Completed

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples (Partners PrEP)

HIV Infections | HIV-1 Infections

Kenya, Uganda
International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID); Comprehensive... and other collaborators

Terminated

Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIV

HIV Infection | Tuberculosis | Pneumocystis Jiroveci Pneumonia

Botswana, South Africa
University of Washington
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding (VIP)

HIV Infections | Herpes Simplex

Kenya
AIDS Clinical Trials Group
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission (OCTANE)

HIV Infections

South Africa, Botswana, Kenya, Malawi, Uganda, Zambia, Zimbabwe
University of Washington
Bill and Melinda Gates Foundation

Completed

Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV Transmission

HIV Infection | Sexually Transmitted Diseases | Herpes Simplex, Genital

South Africa, Kenya, Botswana, Rwanda, Tanzania, Uganda, Zambia
FHI 360

Completed

FEM-PrEP (Truvada®): Study to Assess the Role of Truvada® in Preventing HIV Acquisition in Women

HIV Infections

Kenya, South Africa, Tanzania

Search clinical trials for: HIV seronegativity

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kenya

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations